Side effects - Articles - Page 2

Expert Q&A

How to Choose an Antidepressant

January 1, 2024

Thomas Schwartz, MD.

Professor and Chair, Department of Psychiatry and Behavioral Sciences, Alan and Marlene Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY.

Dr. Schwartz has no financial relationships with companies related to this material.

Thomas Schwartz clarifies how to choose an antidepressant and finds a place for underutilized agents like trazodone and levomilnacipran (Fetzima).

CLINICAL UPDATE

Medications to Treat OCD: What Psychotherapists Need to Know

July 3, 2023

Jessica Goren, PharmD.

Jessica L Goren, PharmD. Instructor in Psychiatry, Cambridge Health Alliance.

Dr. Goren has no financial relationships with companies related to this material.

Learn about common medications for OCD, including SSRIs and clomipramine, along with their side effects, as well as the role of CBT and augmentation strategies in treatment.

Research Update

Marginal Results for Levetiracetam in Mania

April 14, 2023

Kamron Fariba, MD

Kamron Fariba, DO. Dr. Fariba has no financial relationships with companies related to this material.

This anticonvulsant makes its randomized-controlled debut in bipolar mania.

RESEARCH UPDATE

Side Effects in Depression

October 30, 2022

Fernando Espí Forcén, MD. Dr. Forcén has no financial relationships with companies related to this material.

Side effects are burdensome to patients, but do they also get in the way of recovery? This study sought to clarify how side effects change over time and whether they impede recovery in major depressive disorder.

The Benzodiazepine-Stimulant Combo: What Could Go Wrong?

September 25, 2022

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Neurotoxicity, substance use disorders, even traffic accidents can arise from this controversial combination. We look at how to handle it in practice, including how to reduce the use and when the combination might be OK to continue.

RESEARCH UPDATE

Vyvanse for Sluggish Cognitive Tempo in ADHD

August 1, 2022

Thomas Jordan, MD

Thomas Jordan, MD. Dr. Jordan, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

This study won’t tell us if “sluggish cognitive tempo” is a valid disorder, but it does show how Vyvanse works in this controversial subtype of ADHD.
Research Update

Rethinking Topiramate

August 1, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Topiramate can cause psychosis, or treat psychosis; worsen cognition, or improve it; cause depression or… You get the point. A look at the paradoxical world of psychopharmacology.

CLINICAL UPDATE

Six Tips From Prescribing Psychotropics

August 1, 2022

Chris Aiken, MD

Chris Aiken, MD.

Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

New answers to age-old questions, such as adjusting the dose to account for drug interactions, reducing side effects, maintaining weight, and protecting that finicky organ—the kidneys.